Triple
T1445196
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Federal Food, Drug, and Cosmetic Act |
E31160
|
entity |
| Predicate | amendedBy |
P1121
|
FINISHED |
| Object |
Medical Device Amendments of 1976
The Medical Device Amendments of 1976 are U.S. legislation that established a comprehensive regulatory framework for the safety and effectiveness of medical devices, including classification, premarket approval, and performance standards.
|
E165702
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Medical Device Amendments of 1976 | Statement: [Federal Food, Drug, and Cosmetic Act, amendedBy, Medical Device Amendments of 1976]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Medical Device Amendments of 1976 Context triple: [Federal Food, Drug, and Cosmetic Act, amendedBy, Medical Device Amendments of 1976]
-
A.
False Claims Amendments Act of 1986
The False Claims Amendments Act of 1986 is a major U.S. federal law that strengthened the government’s ability to combat fraud against federal programs by expanding whistleblower (qui tam) provisions and increasing penalties for false claims.
-
B.
Stevenson-Wydler Technology Innovation Act of 1980
The Stevenson-Wydler Technology Innovation Act of 1980 is a U.S. federal law designed to promote the transfer of technology from federal laboratories to the private sector and encourage innovation and commercialization of federally funded research.
-
C.
National Cancer Act of 1971
The National Cancer Act of 1971 is a landmark U.S. law that greatly expanded federal funding and coordination for cancer research, prevention, and treatment, helping launch the modern "war on cancer."
-
D.
Federal Technology Transfer Act of 1986
The Federal Technology Transfer Act of 1986 is a U.S. law that strengthened and formalized the process for federal laboratories to collaborate with industry and transfer government-developed technologies into the private sector.
-
E.
Bayh–Dole Act
The Bayh–Dole Act is a landmark 1980 U.S. law that allows universities, small businesses, and other institutions to retain ownership of inventions developed with federal funding, spurring technology transfer and commercialization.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Medical Device Amendments of 1976 Triple: [Federal Food, Drug, and Cosmetic Act, amendedBy, Medical Device Amendments of 1976]
Generated description
The Medical Device Amendments of 1976 are U.S. legislation that established a comprehensive regulatory framework for the safety and effectiveness of medical devices, including classification, premarket approval, and performance standards.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Medical Device Amendments of 1976 Target entity description: The Medical Device Amendments of 1976 are U.S. legislation that established a comprehensive regulatory framework for the safety and effectiveness of medical devices, including classification, premarket approval, and performance standards.
-
A.
False Claims Amendments Act of 1986
The False Claims Amendments Act of 1986 is a major U.S. federal law that strengthened the government’s ability to combat fraud against federal programs by expanding whistleblower (qui tam) provisions and increasing penalties for false claims.
-
B.
Stevenson-Wydler Technology Innovation Act of 1980
The Stevenson-Wydler Technology Innovation Act of 1980 is a U.S. federal law designed to promote the transfer of technology from federal laboratories to the private sector and encourage innovation and commercialization of federally funded research.
-
C.
National Cancer Act of 1971
The National Cancer Act of 1971 is a landmark U.S. law that greatly expanded federal funding and coordination for cancer research, prevention, and treatment, helping launch the modern "war on cancer."
-
D.
Federal Technology Transfer Act of 1986
The Federal Technology Transfer Act of 1986 is a U.S. law that strengthened and formalized the process for federal laboratories to collaborate with industry and transfer government-developed technologies into the private sector.
-
E.
Bayh–Dole Act
The Bayh–Dole Act is a landmark 1980 U.S. law that allows universities, small businesses, and other institutions to retain ownership of inventions developed with federal funding, spurring technology transfer and commercialization.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a4991633388190a4d61b5a98aa407a |
completed | March 1, 2026, 7:52 p.m. |
| NER | Named-entity recognition | batch_69a4c55714588190a95b4f677c21cbaa |
completed | March 1, 2026, 11:01 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ad08c046b08190a448ba2549dc5e00 |
completed | March 8, 2026, 5:27 a.m. |
| NEDg | Description generation | batch_69ad09ec3b388190b492e8959a3617c9 |
completed | March 8, 2026, 5:32 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69ad0aefb1c88190a368d68454a0b9d0 |
completed | March 8, 2026, 5:36 a.m. |
Created at: March 1, 2026, 8 p.m.